COMMUNIQUÉS West-GlobeNewswire

Director/PDMR Shareholding
04/12/2018
DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]
Inovio Announces Initiation of “MD Anderson’s HPV-Related Cancers Moon Shot” Phase 2 Trial in New HPV Indications
04/12/2018
Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several HPV-related cancers PLYMOUTH MEETING, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inovio [...]
Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission
04/12/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
AzurRx BioPharma to Present at Upcoming Investor Conferences
04/12/2018
BROOKLYN, N.Y., Dec. 04, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Interface Biologics Announces New V.P., Business Development
04/12/2018
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical applications, is [...]
Biotricity Actively Pursues Holter Market with Bioflux Product Offering
04/12/2018
Company Leverages Connectivity-Enabled Holter Capability to Expand Market Reach REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare [...]
NexImmune Completes Sr. Leadership Team with New VP Hires
04/12/2018
Naimish Pandya, MD assumes role of VP & Head, Clinical Development Alex Matschiner, MS ChE assumes role of VP, Protein Process Development GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- NexImmune, an emerging [...]
Media Advisory: Canadian Blood Services board meeting open to the public
04/12/2018
OTTAWA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- On December 6, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]
Avis aux médias : Le conseil d’administration de la Société canadienne du sang ouvre sa prochaine réunion au public
04/12/2018
OTTAWA, 04 déc. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion du conseil d’administration qui aura lieu au siège social de l’organisation, [...]
BioSyent Announces Normal Course Issuer Bid
04/12/2018
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of Intention to Make [...]
Caelum Biosciences Announces Two Oral Presentations of Additional Data from Phase 1b Study of Anti-Amyloid mAb CAEL-101 and Preclinical Imaging Study at 60th American Society of Hematology Annual Meeting
04/12/2018
Phase 1b data confirm efficacy in AL Amyloidosis with two cardiac markers correlated with survival Preclinical data demonstrate the potential of using radiolabeled CAEL-101 for real-time imaging of human amyloidosis in [...]
aTyr Pharma Announces Initiation of Phase 1b/2a Study of ATYR1923 in Patients with Pulmonary Sarcoidosis and Collaboration with the Foundation for Sarcoidosis Research (FSR)
04/12/2018
FSR Clinical Studies Network to assist with clinical site initiation to expedite patient enrollment SAN DIEGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the [...]
Nu-Med Plus, Inc. President Helps Lead Call for New Innovation in Inhaled Nitric Oxide Industry
04/12/2018
Nu-Med Plus President Jeff Robins published an open letter calling for greater awareness of inhaled nitric oxide to potentially advance treatment options for malaria, COPD, tuberculosis and ARDS SALT LAKE CITY, Dec. 04 [...]
Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence
04/12/2018
MIAMI, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top [...]
BrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MND
04/12/2018
Poster highlights enrichment strategies for clinical trials in ALS NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative autologous adult stem [...]
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
04/12/2018
Massachusetts Institute of Technology and Versitech Limited patent, licensed exclusively by Arch, is maintained without amendment as prior lower court decision is affirmed. FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE [...]
Moleculin Announces Breakthrough Discovery for its WP1066
04/12/2018
WP1066 shown to counteract resistance to checkpoint blockades HOUSTON, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company [...]
OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia
04/12/2018
Approval gives OpGen its first commercial product in the region; paves way for broader expansion into South American markets GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced [...]
Marinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients
04/12/2018
Predictive biomarker also identified in PCDH19-related pediatric epilepsy RADNOR, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical [...]

Pages